{
    "title": [
        {
            "start": 1,
            "end": 157,
            "text": "The Level of Ischemic Modified Albumin (IMA) as Risk Marker for Cardio Vascular Disease (CVD) among some diabetic patients (type II) in Khartoum State-Sudan"
        },
        {
            "start": 670,
            "end": 826,
            "text": "The Level of Ischemic Modified Albumin (IMA) as Risk Marker for Cardio Vascular Disease (CVD) among some diabetic patients (type II) in Khartoum State-Sudan"
        }
    ],
    "abstract": [
        {
            "start": 1012,
            "end": 3196,
            "text": "Background: Recent literature reports show large interest in ischemic modified albumin (IMA) biochemical marker for detection of myocardial injury.Special attention is focused in estimation of IMA test for the diagnosis and evaluation of myocardial ischemia as well as others acute coronary syndrome in emergency patients.Objective: evaluation of ischemia-modified albumin (IMA) in well controlled and uncontrolled patients with type 2 diabetes mellitus and estimation of its connection with cardiovascular disease.Measurement the levelof IMA as risk marker for cardio vascular disease (CVD) in diabetic patients that arrived to emergency department with signs and symptoms of CVD.Methodology: 140 subjects enrolled in this study ,70 diabetes mellitus patients with signs and symptoms of CVD, and other 70 apparently non diabetic healthy subjects' as controls, , the levels of biomarker IMA was measured as the risk marker of CVDin controlled and uncontrolled diabeticpatients with type2,the Diagnostic potential was evaluated by receiver operating characteristic analysis and their relationships were analyzed.This study was done in Shab Hospital, Khartoum.Period from 1st of February 2015 to October 2015.Results: The results showed that CVD were predominant among diabetic female 57 % and peaked at age 75.5 years among 40-75 year old.The IMA was significantly increase in diabetic patients when compare with normal healthy group with cut off value ( 0.97 IU/L ), and there is also significantly increase in IMA level in uncontrolled diabetic patients (Mean ± SD; 14.70 + 10.66) that presented with acute chest pain and havea signs and symptoms of cardiac ischemia when compared with the wellcontrolled diabetic patients(Mean ± SD; 3.74 ± 3.68).controlled and uncontrolled diabetic patients were determined by the level of their HBA1c and comparison with the means of IMA level in their serum.Conclusions: increase IMA level in poor control and long stand diabetic patients could help to identify the higher risk for develop to CVD, and The most common complication such as suffering from local or systemic hypoxic conditions, as acute ischemic stroke, peripheral vascular disease."
        }
    ],
    "authoraffiliation": [
        {
            "start": 185,
            "end": 251,
            "text": "Faculty of medical laboratory science\nOmdurman Islamic university"
        },
        {
            "start": 253,
            "end": 313,
            "text": "Faculty of medical laboratory science\nSharq Al Nile College"
        },
        {
            "start": 315,
            "end": 360,
            "text": "Pediatric Department\nturkey hospital Khartoum"
        },
        {
            "start": 372,
            "end": 438,
            "text": "Faculty of medical laboratory science\nOmdurman Islamic university"
        },
        {
            "start": 454,
            "end": 520,
            "text": "Faculty of medical laboratory science\nOmdurman Islamic university"
        },
        {
            "start": 540,
            "end": 606,
            "text": "Faculty of medical laboratory science\nOmdurman Islamic university"
        },
        {
            "start": 617,
            "end": 668,
            "text": "Sudan Journal of Medical Sciences Isam Sadik et al"
        }
    ],
    "author": [
        {
            "start": 608,
            "end": 614,
            "text": "Ibnouf"
        }
    ],
    "doi": [
        {
            "start": 875,
            "end": 907,
            "text": "10.18502/sjms.v12i4.1354Received"
        },
        {
            "start": 5707,
            "end": 5731,
            "text": "10.18502/sjms.v12i4.1354"
        },
        {
            "start": 9893,
            "end": 9931,
            "text": "10.18502/sjms.v12i4.1354infarction.The"
        },
        {
            "start": 11438,
            "end": 11470,
            "text": "10.18502/sjms.v12i4.1354duration"
        },
        {
            "start": 12304,
            "end": 12328,
            "text": "10.18502/sjms.v12i4.1354"
        },
        {
            "start": 12776,
            "end": 12805,
            "text": "10.18502/sjms.v12i4.1354plate"
        },
        {
            "start": 14049,
            "end": 14073,
            "text": "10.18502/sjms.v12i4.1354"
        },
        {
            "start": 16868,
            "end": 16892,
            "text": "10.18502/sjms.v12i4.1354"
        },
        {
            "start": 17510,
            "end": 17542,
            "text": "10.18502/sjms.v12i4.1354Diabetes"
        }
    ]
}